| Neutrophils: Cinderella of innate immune system V Kumar, A Sharma International immunopharmacology 10 (11), 1325-1334, 2010 | 596 | 2010 |
| Toll-like receptors in immunity and inflammatory diseases: Past, present, and future K Vijay International immunopharmacology 59, 391-412, 2018 | 575 | 2018 |
| Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury V Kumar Frontiers in immunology 11, 1722, 2020 | 353 | 2020 |
| Toll-like receptors in the pathogenesis of neuroinflammation V Kumar Journal of Neuroimmunology 332, 16-30, 2019 | 275 | 2019 |
| Adenosine: an endogenous modulator of innate immune system with therapeutic potential V Kumar, A Sharma European journal of pharmacology 616 (1-3), 7-15, 2009 | 236 | 2009 |
| Mast cells: emerging sentinel innate immune cells with diverse role in immunity V Kumar, A Sharma Molecular immunology 48 (1-3), 14-25, 2010 | 156 | 2010 |
| Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets Kumar INTERNATIONAL IMMUNOPHARMACOLOGY 89 (B), 107087, 2020 | 152 | 2020 |
| Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? V Kumar Purinergic signalling 9, 145-165, 2013 | 122 | 2013 |
| Targeting macrophage immunometabolism: dawn in the darkness of sepsis V Kumar International immunopharmacology 58, 173-185, 2018 | 118 | 2018 |
| A sting to inflammation and autoimmunity V Kumar Journal of leukocyte biology 106 (1), 171-185, 2019 | 86 | 2019 |
| T cells and their immunometabolism: a novel way to understanding sepsis immunopathogenesis and future therapeutics V Kumar European journal of cell biology 97 (6), 379-392, 2018 | 80 | 2018 |
| Inflammasomes: Pandora’s box for sepsis V Kumar Journal of inflammation research, 477-502, 2018 | 77 | 2018 |
| Is neuroimmunomodulation a future therapeutic approach for sepsis? V Kumar, A Sharma International immunopharmacology 10 (1), 9-17, 2010 | 75 | 2010 |
| Macrophages: the potent immunoregulatory innate immune cells V Kumar Macrophage Act.-Biol. Dis, 2019 | 73 | 2019 |
| Innate lymphoid cells: new paradigm in immunology of inflammation V Kumar Immunology letters 157 (1-2), 23-37, 2014 | 70 | 2014 |
| The trinity of cGAS, TLR9, and ALRs guardians of the cellular galaxy against host-derived self-DNA V Kumar Frontiers in Immunology 11, 3902, 2021 | 58 | 2021 |
| Immunometabolism: another road to sepsis and its therapeutic targeting V Kumar Inflammation 42 (3), 765-788, 2019 | 47 | 2019 |
| Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity S Kiran, V Kumar, S Kumar, RL Price, UP Singh Cells 10 (5), 1004, 2021 | 45 | 2021 |
| How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? V Kumar International Reviews of Immunology 40 (1-2), 72-107, 2021 | 45 | 2021 |
| Thalidomide: an old drug with new action V Kumar, S Chhibber Journal of Chemotherapy 23 (6), 326-334, 2011 | 43 | 2011 |
